Galit Gonen

Head of IP Novartis

Contact

Published by this author:

Industry opinion: Originator pharma disputes proving tricky

Galit Gonen, head of IP at Novartis Pharma, delves into the unique challenges that arise when originator partnerships break down

Galit Gonen, March 31, 2021